124 related articles for article (PubMed ID: 37150673)
1. β1-Integrin blockade prevents podocyte injury in experimental models of minimal change disease.
Cara-Fuentes G; Verma R; Venkatareddy M; Bauer C; Piani F; Aksoy ST; Vazzalwar N; Garcia GE; Banks M; Ordoñez FA; de Lucas-Collantes C; Bjornstad P; González Rodríguez JD; Johnson RJ; Garg P
Nefrologia (Engl Ed); 2024; 44(1):90-99. PubMed ID: 37150673
[TBL] [Abstract][Full Text] [Related]
2. Activation of integrin β1-focal adhesion kinase-RasGTP pathway plays a critical role in TGF beta1-induced podocyte injury.
Zhang YJ; Tian ZL; Yu XY; Zhao XX; Yao L
Cell Signal; 2013 Dec; 25(12):2769-79. PubMed ID: 24036212
[TBL] [Abstract][Full Text] [Related]
3. Plectin protects podocytes from adriamycin-induced apoptosis and F-actin cytoskeletal disruption through the integrin α6β4/FAK/p38 MAPK pathway.
Ni Y; Wang X; Yin X; Li Y; Liu X; Wang H; Liu X; Zhang J; Gao H; Shi B; Zhao S
J Cell Mol Med; 2018 Nov; 22(11):5450-5467. PubMed ID: 30187999
[TBL] [Abstract][Full Text] [Related]
4. Proteins Secreted by Lung Cancer Cells Induce the Onset of Proteinuria via Focal Adhesion Kinase Signaling in Mice.
Niu SW; Wu CH; Chen HC; Yang CJ; Chang JM; Chang EE; Chuang HH; Chiu YW; Zhen YY; Hung CC; Hwang SJ
Lab Invest; 2023 Aug; 103(8):100156. PubMed ID: 37119854
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of podocyte FAK protects against proteinuria and foot process effacement.
Ma H; Togawa A; Soda K; Zhang J; Lee S; Ma M; Yu Z; Ardito T; Czyzyk J; Diggs L; Joly D; Hatakeyama S; Kawahara E; Holzman L; Guan JL; Ishibe S
J Am Soc Nephrol; 2010 Jul; 21(7):1145-56. PubMed ID: 20522532
[TBL] [Abstract][Full Text] [Related]
6. CD147/Basigin Deficiency Prevents the Development of Podocyte Injury through FAK Signaling.
Yoshioka T; Kosugi T; Masuda T; Watanabe T; Ryuge A; Nagaya H; Maeda K; Sato Y; Katsuno T; Kato N; Ishimoto T; Yuzawa Y; Maruyama S; Kadomatsu K
Am J Pathol; 2019 Jul; 189(7):1338-1350. PubMed ID: 31014956
[TBL] [Abstract][Full Text] [Related]
7. "Idiopathic" minimal change nephrotic syndrome: a podocyte mystery nears the end.
Chugh SS; Clement LC
Am J Physiol Renal Physiol; 2023 Dec; 325(6):F685-F694. PubMed ID: 37795536
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin inhibitors ameliorate PAN-induced podocyte injury through the NFAT-Angptl4 pathway.
Shen X; Zhang Y; Lin C; Weng C; Wang Y; Feng S; Wang C; Shao X; Lin W; Li B; Wang H; Chen J; Jiang H
J Pathol; 2020 Nov; 252(3):227-238. PubMed ID: 32686149
[TBL] [Abstract][Full Text] [Related]
9. TGF-β1 modulates podocyte migration by regulating the expression of integrin-β1 and -β3 through different signaling pathways.
Chen CA; Chang JM; Chang EE; Chen HC; Yang YL
Biomed Pharmacother; 2018 Sep; 105():974-980. PubMed ID: 30021392
[TBL] [Abstract][Full Text] [Related]
10. A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules.
Lee HW; Khan SQ; Faridi MH; Wei C; Tardi NJ; Altintas MM; Elshabrawy HA; Mangos S; Quick KL; Sever S; Reiser J; Gupta V
J Am Soc Nephrol; 2015 Nov; 26(11):2741-52. PubMed ID: 25858967
[TBL] [Abstract][Full Text] [Related]
11. LPS and PAN-induced podocyte injury in an in vitro model of minimal change disease: changes in TLR profile.
Srivastava T; Sharma M; Yew KH; Sharma R; Duncan RS; Saleem MA; McCarthy ET; Kats A; Cudmore PA; Alon US; Harrison CJ
J Cell Commun Signal; 2013 Mar; 7(1):49-60. PubMed ID: 23161414
[TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanisms of Proteinuria in Minimal Change Disease.
Purohit S; Piani F; Ordoñez FA; de Lucas-Collantes C; Bauer C; Cara-Fuentes G
Front Med (Lausanne); 2021; 8():761600. PubMed ID: 35004732
[TBL] [Abstract][Full Text] [Related]
13. Protein tyrosine phosphatase 1B inhibition protects against podocyte injury and proteinuria.
Kumagai T; Baldwin C; Aoudjit L; Nezvitsky L; Robins R; Jiang R; Takano T
Am J Pathol; 2014 Aug; 184(8):2211-24. PubMed ID: 24951831
[TBL] [Abstract][Full Text] [Related]
14. [New insight in pathogenesis of podocyte disfunction in minimal change disease].
Liu S; Chen J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Mar; 45(2):214-8. PubMed ID: 27273997
[TBL] [Abstract][Full Text] [Related]
15. Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance.
Tian X; Kim JJ; Monkley SM; Gotoh N; Nandez R; Soda K; Inoue K; Balkin DM; Hassan H; Son SH; Lee Y; Moeckel G; Calderwood DA; Holzman LB; Critchley DR; Zent R; Reiser J; Ishibe S
J Clin Invest; 2014 Mar; 124(3):1098-113. PubMed ID: 24531545
[TBL] [Abstract][Full Text] [Related]
16. Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease.
George B; Verma R; Soofi AA; Garg P; Zhang J; Park TJ; Giardino L; Ryzhova L; Johnstone DB; Wong H; Nihalani D; Salant DJ; Hanks SK; Curran T; Rastaldi MP; Holzman LB
J Clin Invest; 2012 Feb; 122(2):674-92. PubMed ID: 22251701
[TBL] [Abstract][Full Text] [Related]
17. Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.
Potla U; Ni J; Vadaparampil J; Yang G; Leventhal JS; Campbell KN; Chuang PY; Morozov A; He JC; D'Agati VD; Klotman PE; Kaufman L
J Clin Invest; 2014 Apr; 124(4):1757-69. PubMed ID: 24642466
[TBL] [Abstract][Full Text] [Related]
18. Synaptopodin expression in idiopathic nephrotic syndrome of childhood.
Srivastava T; Garola RE; Whiting JM; Alon US
Kidney Int; 2001 Jan; 59(1):118-25. PubMed ID: 11135064
[TBL] [Abstract][Full Text] [Related]
19. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of integrin β1 and focal adhesion kinase in renal glomeruli under various hemodynamic conditions.
Yuan X; Wang W; Wang J; Yin X; Zhai X; Wang L; Li K; Li Z
PLoS One; 2014; 9(4):e94212. PubMed ID: 24705394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
